| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NPIP | NPIPA1 NPIPB3 NPIPA3 NPIPB15 NPIPB5 NPIPB13 NPIPA7 NPIPA2 NPIPB9 NPIPB2 | 4.46e-25 | 14 | 39 | 10 | IPR009443 |
| Domain | EPHD | 9.56e-04 | 22 | 39 | 2 | PS51805 | |
| Domain | RGS | 2.42e-03 | 35 | 39 | 2 | PF00615 | |
| Domain | RGS | 2.42e-03 | 35 | 39 | 2 | SM00315 | |
| Domain | RGS | 2.56e-03 | 36 | 39 | 2 | PS50132 | |
| Domain | RGS | 3.00e-03 | 39 | 39 | 2 | IPR016137 | |
| Domain | Zinc_finger_PHD-type_CS | 8.13e-03 | 65 | 39 | 2 | IPR019786 | |
| Domain | PHD | 1.07e-02 | 75 | 39 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 1.18e-02 | 79 | 39 | 2 | IPR019787 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.81e-04 | 12 | 24 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.81e-04 | 12 | 24 | 2 | MM15623 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.72e-04 | 17 | 24 | 2 | MM15584 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 9.24e-09 | 4 | 47 | 3 | 18055785 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 1.63e-07 | 92 | 47 | 5 | 10493829 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 1.79e-06 | 2 | 47 | 2 | 11586358 | |
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 5.36e-06 | 3 | 47 | 2 | 11948212 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 6.87e-06 | 90 | 47 | 4 | 15616553 | |
| Pubmed | Genetic loci contributing to age-related hippocampal lesions in mice. | 1.78e-05 | 5 | 47 | 2 | 12828934 | |
| Pubmed | 2.40e-04 | 17 | 47 | 2 | 20627871 | ||
| Pubmed | 1.03e-03 | 35 | 47 | 2 | 33864728 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 2.40e-08 | 172 | 47 | 6 | chr16p12 | |
| Cytoband | 16p11.2 | 1.57e-06 | 191 | 47 | 5 | 16p11.2 | |
| Cytoband | 16p13.11 | 1.76e-06 | 23 | 47 | 3 | 16p13.11 | |
| Cytoband | 16p12.2 | 7.62e-06 | 37 | 47 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 9.78e-06 | 278 | 47 | 5 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 7.48e-05 | 426 | 47 | 5 | chr16p13 | |
| Cytoband | 11q13.1 | 1.93e-03 | 63 | 47 | 2 | 11q13.1 | |
| Cytoband | 19q13.33 | 5.33e-03 | 106 | 47 | 2 | 19q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 1.03e-02 | 149 | 47 | 2 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.13e-02 | 454 | 47 | 3 | chr11q13 | |
| GeneFamily | Regulators of G-protein signaling | 2.41e-04 | 21 | 20 | 2 | 720 | |
| GeneFamily | PHD finger proteins | 4.39e-03 | 90 | 20 | 2 | 88 | |
| GeneFamily | PDZ domain containing | 1.21e-02 | 152 | 20 | 2 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.33e-02 | 160 | 20 | 2 | 555 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-06 | 187 | 47 | 5 | 88d20f150df61ef0e3ee0c3e9895b094920c4b09 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-06 | 187 | 47 | 5 | 158c2c003fd225ba61793fb06eece232fb063d05 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-06 | 189 | 47 | 5 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-06 | 189 | 47 | 5 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 166 | 47 | 4 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 170 | 47 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.62e-05 | 177 | 47 | 4 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.62e-05 | 177 | 47 | 4 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-05 | 178 | 47 | 4 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-05 | 178 | 47 | 4 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 179 | 47 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-05 | 181 | 47 | 4 | 1110a0375189c034e6b02e6ebceb7084e4590114 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-05 | 188 | 47 | 4 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-05 | 188 | 47 | 4 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.67e-05 | 189 | 47 | 4 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.67e-05 | 189 | 47 | 4 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| Disease | triglycerides to total lipids in large LDL percentage | 4.25e-05 | 51 | 39 | 3 | EFO_0022331 | |
| Disease | retinal layer thickness measurement | 6.93e-05 | 60 | 39 | 3 | EFO_0600002 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.32e-04 | 13 | 39 | 2 | EFO_0021477 | |
| Disease | phospholipids:total lipids ratio | 2.27e-04 | 227 | 39 | 4 | EFO_0020946 | |
| Disease | colon cancer (is_implicated_in) | 1.04e-03 | 36 | 39 | 2 | DOID:219 (is_implicated_in) | |
| Disease | lysophosphatidylcholine 20:3 measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0010362 | |
| Disease | retinal nerve fibre layer thickness measurement | 1.49e-03 | 43 | 39 | 2 | EFO_0600004 | |
| Disease | cholesteryl ester 20:3 measurement | 1.92e-03 | 49 | 39 | 2 | EFO_0010347 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.00e-03 | 50 | 39 | 2 | EFO_0022334 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.25e-03 | 53 | 39 | 2 | EFO_0022340 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.33e-03 | 54 | 39 | 2 | EFO_0022244 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.69e-03 | 58 | 39 | 2 | EFO_0022338 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.23e-03 | 224 | 39 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.27e-03 | 225 | 39 | 3 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.67e-03 | 291 | 39 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.89e-03 | 94 | 39 | 2 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 7.18e-03 | 96 | 39 | 2 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 7.62e-03 | 99 | 39 | 2 | EFO_0004639, EFO_0008595 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 7.62e-03 | 99 | 39 | 2 | EFO_0004574, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSPSAPEPPKADLFE | 381 | P55198 | |
| LPDPQTASALPDPPA | 161 | P09564 | |
| PTPQSSDPDDTPPKL | 281 | O95503 | |
| DRDDSKLPPPPTLEP | 826 | Q9ULD4 | |
| SESPEEPLPNLKPKP | 786 | Q53SF7 | |
| PADLLPTPDPAAQPS | 846 | Q2TAZ0 | |
| DSKSNLPPEPVLPPE | 101 | Q99618 | |
| PLPPSADDNLKTPPE | 311 | Q92617 | |
| PLPPSAPPSADDNIK | 851 | Q92617 | |
| LTPLPPSAPPSADDN | 891 | Q92617 | |
| PLPPSADDNLKTPPL | 916 | Q92617 | |
| TPPEDPDSQPPSSKR | 21 | Q09MP3 | |
| LPPGQDLPPNKDSPS | 716 | P49796 | |
| PLPPSADDNLKTPPE | 296 | Q9UND3 | |
| PLPPSADDNLKTPPE | 311 | F8W0I5 | |
| PLPPSAPPSADDNIK | 771 | F8W0I5 | |
| STEDLSPPSPPLPKE | 856 | Q13127 | |
| SPPSPPLPKENLREE | 861 | Q13127 | |
| PAPLPPEDAPNAASL | 106 | P46695 | |
| PLSPPQPASPAEEDK | 341 | P14314 | |
| SSSDDADLPPPPPLL | 331 | P34910 | |
| PLPPSADDNLKTPPE | 311 | A8MRT5 | |
| PLPPSAPPSADDNIK | 976 | A8MRT5 | |
| PPSPLPPSVDDNLKE | 291 | O75200 | |
| LPPSPLPPSVDDNLK | 311 | O75200 | |
| PLPPSADDNLKTPPE | 296 | F8WFD2 | |
| PPSAPPSADDNLKTP | 336 | E9PIF3 | |
| PLPPSADDNLKTPPE | 311 | C9JG80 | |
| PLPPSAPPSADDNIK | 521 | C9JG80 | |
| LTPLPPSAPPSADDN | 561 | C9JG80 | |
| PLPPSAPPSADDNIK | 981 | C9JG80 | |
| LPPSPLPPSVDDNLK | 306 | A6NHN6 | |
| PLPPSAPPSADDNIK | 441 | E5RHQ5 | |
| LTPLPPSAPPSADDN | 481 | E5RHQ5 | |
| PLPPSAPPSADDNIK | 991 | E5RHQ5 | |
| PLPPSADDNLKTPPL | 1056 | E5RHQ5 | |
| PELPPLPASANEEPS | 56 | Q8TD57 | |
| PEAPTPSPLDPNSDK | 736 | Q8NHY3 | |
| EEPSIPEPPKPAADQ | 581 | Q12934 | |
| LPDPPAPAESPKELD | 81 | A0A0U1RRI6 | |
| PPPNLPDPKFESKAA | 26 | P19235 | |
| KTPDSPPTPAPLLLD | 701 | Q16584 | |
| PPSPLPPSVDDNLKE | 306 | F8W1W9 | |
| LPPSPLPPSVDDNLK | 326 | F8W1W9 | |
| NKPEFEDSNPSPLPP | 1716 | Q12923 | |
| PLPPSADDNLKTPPE | 311 | A6NJU9 | |
| PLPPSAPPSADDNIK | 521 | A6NJU9 | |
| LTPLPPSAPPSADDN | 561 | A6NJU9 | |
| PLPPSAPPSADDNIK | 771 | A6NJU9 | |
| LTPLPPSAPPSADDN | 811 | A6NJU9 | |
| PLPPSAPPSADDNIK | 981 | A6NJU9 | |
| PPSAPPSADDNLKTP | 336 | E9PJI5 | |
| PPSAPPSADDNLKTP | 336 | P0DM63 | |
| QPDPSSEERPPALPL | 241 | Q9BQG1 | |
| KKPPSLPPPATEEDN | 171 | Q8NE09 | |
| CKDPTPIEFSPDPLP | 281 | Q8WZA1 | |
| ADPLESPPTAPDPAL | 211 | Q9BWN1 | |
| MTKNLDPDPEPPSPD | 236 | Q9BUA3 | |
| LPSPLPEQPLDSPAA | 556 | Q17R89 | |
| PEQPLDSPAAPALSP | 561 | Q17R89 | |
| NTPPPTPPEQDKEDF | 181 | Q9GZN2 | |
| SNDLPPKVGPLSPDE | 191 | Q8IXP5 | |
| PEKSDLSSPPQTPPD | 841 | Q8WYR1 | |
| TPLPPSAPPSADDNL | 306 | A6NJ64 | |
| PKSPAEPPAPEKQDL | 506 | A6NMK8 | |
| SPPLPDPEDLKNLPS | 506 | E9PAV3 | |
| PAEAPKEAPPEDQSP | 31 | Q14324 | |
| PPPQAPNDEGDPKAL | 56 | Q99608 |